Stock Analysis

UBS Group Full Year 2023 Earnings: EPS Misses Expectations

UBS Group (VTX:UBSG) Full Year 2023 Results

Key Financial Results

Revenue: US$39.6b (up 16% from FY 2022).
Net income: US$27.8b (up 265% from FY 2022).
Profit margin: 70% (up from 22% in FY 2022).
EPS: US$8.83 (up from US$2.34 in FY 2022).

revenue-and-expenses-breakdown — SWX:UBSG Revenue and Expenses Breakdown April 3rd 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

UBS Group EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.7%.

The primary driver behind last 12 months revenue was the UBS Business Divisions and Group Functions - Global Wealth Management segment contributing a total revenue of US$21.0b (53% of total revenue). The largest operating expense was General & Administrative costs, amounting to US$33.3b (283% of total expenses). Explore how UBSG's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 5.2% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Capital Markets industry in Switzerland.

Performance of the Swiss Capital Markets industry.

The company's shares are down 1.8% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 4 warning signs for UBS Group (1 can't be ignored!) that you need to be mindful of.

Valuation is complex, but we're helping make it simple.

Find out whether UBS Group is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.